Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06647615 · ClinicalTrials.gov registry record · NA

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

A NA study of Crohn's Disease and Abdominal Pain (AP), sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06647615 is a NA study of Crohn's Disease and Abdominal Pain (AP) that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 15 participants, below the 2,415-participant average among 104 other Crohn's Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06647615, a NA study of Crohn's Disease and Abdominal Pain (AP), is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite lack of evidence of active inflammation improve with the use of virtual reality (VR).

Interventions

  • DEVICE VR headset

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-05-24
Est. Completion 2026-12-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06647615

The ClinicalTrials.gov registry entry for NCT06647615 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,415-participant average among 104 other Crohn's Disease trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Crohn's Disease appearing as the primary indexed condition, and to 1 intervention - of which VR headset is the first listed.

NCT06647615 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06647615 about?

NCT06647615 is a clinical study titled "A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease". The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite lack of evidence of active inflammation improve with the use of virtual reality (VR).

What is the current status of trial NCT06647615?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-05-24. Estimated completion is 2026-12-31.

What conditions does trial NCT06647615 study?

This clinical trial studies the following conditions: Crohn's Disease, Abdominal Pain (AP).

What interventions are being tested in trial NCT06647615?

The interventions under investigation include: VR headset (DEVICE).

Who is sponsoring clinical trial NCT06647615?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06647615 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Crohn's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.